Nine Masts Capital
AZN icon

Nine Masts Capital’s AstraZeneca AZN Stock Holding History

Nine Masts Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.36M Buy
+8,400
New +$1.4M 0.16% 60
2026
Q2 		– Sell
-2,000
Closed -$394K – 181
2026
Q1 		$394K Buy
+2,000
New +$386K 0.06% 94

Other funds holding AZN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Nine Masts Capital's AZN Position: Q3 2026 in Review

Nine Masts Capital opened a new position in AstraZeneca (AZN) in Q3 2026: 8,400 shares worth $1.36M. The stake represents 0.16% of the portfolio and ranks #60 among its holdings. This is a return to the name: Nine Masts Capital previously reported a position in AZN as recently as Q1 2026.

Nine Masts Capital first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 918 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Nine Masts Capital held 8,400 shares of AstraZeneca worth $1.36M as of Q3 2026.
  • AstraZeneca was a new Nine Masts Capital position in Q3 2026.
  • AstraZeneca made up 0.16% of Nine Masts Capital's portfolio in Q3 2026, its #60 holding.
  • Nine Masts Capital first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • 918 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Nine Masts Capital's 13F filing for Q3 2026, filed 9 Nov 2026.